文献速递主动脉疾病

0区和1区主动脉弓腔内修复术的手术相关费用与中期结局

Procedure-Associated Costs and Mid-Term Outcomes of Endovascular Zone 0 and Zone 1 Aortic Arch Repair.
PubMed 文献 · Ann Vasc Surg · 2021-11-12

单中心回顾性研究纳入2011年4月至2019年8月间因近端主动脉弓病变行0区或1区TEVAR的10例无法开放手术患者,随访平均19.3个月,中期结局良好,但平均净技术利润为负,9例患者净技术利润为负。

要点

  • 10例患者(0区6例,1区4例)均被拒绝开放主动脉弓重建。
  • 30天内1例卒中、1例死亡,旁路及分支血管通畅率100%。
  • 平均总技术成本105164±59338美元,平均净技术利润-25055±18746美元。

核心结论

  • 对于被认为开放修复风险过高的患者,近端主动脉弓腔内修复与良好的中期结局相关。
  • 报销未能充分覆盖治疗成本,几乎所有病例的净技术利润为负。
  • 为保持财务可持续性,应努力优化主动脉弓TEVAR的实施,并倡导与相关成本相称的报销。

研究设计与样本

  • 单中心回顾性病历审查,纳入2011年4月至2019年8月期间所有接受TEVAR的患者。
  • 按近端覆膜支架延伸范围分为0区或1区修复,共10例(0区6例,1区4例)。
  • 技术成本、收入和利润来自医院财务部门。

主要发现

  • 患者以女性为主(8例,80%),平均年龄72.8±5.5岁。
  • TEVAR在5例无症状患者中择期进行,3例有症状患者紧急进行,2例破裂患者急诊进行。
  • 4例患者行TEVAR加解剖外旁路,另4例接受平行支架移植,1例接受分支胸主动脉覆膜支架,1例接受原位激光开窗后分支支架移植。
  • 术后30天内1例患者发生卒中,1例患者死亡。
  • 随访期间(平均19.3个月)旁路和分支血管通畅率为100%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic endovascular aortic repair (TEVAR) of proximal aortic arch pathology provides a less-invasive treatment option for high-risk patients ineligible for open arch reconstruction. However, the fiscal impact of these techniques remains unclear. Therefore, our objective was to characterize the mid-term outcomes after Zone 0 and Zone 1 TEVAR and describe the associated technical costs, revenues, and net margins at a single tertiary medical center. METHODS: We examined all patients who underwent TEVAR between April 2011 and August 2019 via retrospective chart review. Patients were categorized by proximal endograft extent to identify Zone 0 or Zone 1 repairs. Procedural characteristics and outcomes were described. Technical costs, revenues, and margins were obtained from the hospital finance department. RESULTS: We identified 10 patients (6 Zone 0, 4 Zone 1) who were denied open arch reconstruction. Patients were predominantly female (n = 8; 80%) and the mean age was 72.8 ± 5.5 years. TEVAR was performed in 5 asymptomatic patients, urgently in 3 symptomatic patients, and emergently in 2 ruptured patients. TEVAR plus extra-anatomic bypass was performed in 4 patients. Another 4 patients also received parallel stent-grafting while 1 patient received a branched thoracic endograft and yet another an in-situ laser fenestration followed by branch stent grafting. Within the 30-day postoperative period, 1 patient experienced stroke and 1 patient died. Bypass and branch vessel patency were 100% through the duration of follow-up (mean 19.3 months). Mean total technical cost associated with all procedures or repair stages was $105,164 ± $59,338 while mean net technical margin was -$25,055 ± $18,746. The net technical margin was negative for 9 patients. CONCLUSIONS: Endovascular repair of the proximal aortic arch is associated with good mid-term outcomes in patients considered too high-risk for open repair. However, reimbursement does not adequately cover treatment cost, with net technical margins being negative in nearly all cases. To remain financially sustainable, efforts should be made to both optimize aortic arch TEVAR delivery as well as advocate for reimbursement commensurate with associated costs.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Barnes JA, Wanken ZJ, Columbo JA, et al. Procedure-Associated Costs and Mid-Term Outcomes of Endovascular Zone 0 and Zone 1 Aortic Arch Repair. Ann Vasc Surg. 2021. PMID: 34780945. doi:10.1016/j.avsg.2021.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。